BIOVIE INC (BIVI) Stock Income Statement
NASDAQ:BIVI - Nasdaq - US09074F4054 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-6-30) | 2023 (2023-6-30) | 2022 (2022-6-30) | 2021 (2021-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 18.94M | 32.01M | 45.08M | 27.25M | 138.05M | |||
| Research and Development | 10.09M | N/A | 33.30M | 17.26M | 133.19M | |||
| Selling, General, and Administrative Expenses | 8.62M | 8.86M | 11.55M | 9.77M | 4.64M | |||
| Operating Income | -18.94M | -32.01M | -45.08M | -27.25M | -138.05M | |||
| Interest Income/Expense | 199.60K | N/A | -5.18M | 1.17M | 7.74M | |||
| Other Income/Expense | N/A | N/A | N/A | N/A | N/A | |||
| Non Recurring Items | -255.00K | 10.00K | N/A | 0.00 | 60.00K | |||
| Income Before Taxes | -18.99M | -32.00M | -50.26M | -26.08M | -130.25M | |||
| Net Income | -19.36M | -33.00M | -50.26M | -26.08M | -183.85M | |||
| EBITDA | -18.71M | -31.78M | -44.85M | -27.02M | -137.82M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.12 | -7.30 | -1.55 | -1.06 | -14.82 | |||
| Non GAAP EPS | N/A | N/A | -15.60 | N/A | N/A | |||
| Statistics | ||||||||
All data in USD